Camurus is a research-based pharmaceutical company that develops medicines for severe and chronic conditions. It offers Buvidal, a buprenorphine injection for opioid dependence treatment. The company also has expertise in the research and development of pipelines used to address pulmonary arterial hypertension, chronic pain, genetic obesity disorders, acromegaly, and other medical needs.